Cargando…
Intratumor Heterogeneity of HLA-G Expression in Cancer Lesions
Signaling pathway between human leukocyte antigen (HLA)-G and immune inhibitory receptors immunoglobulin-like transcript (ILT)-2/4 has been acknowledged as one of immune checkpoints, and as a potential target for cancer immunotherapy. Like other immune checkpoints, inter- and even intratumor heterog...
Autores principales: | Zhang, Xia, Lin, Aifen, Han, Qiu-Yue, Zhang, Jian-Gang, Chen, Qiong-Yuan, Ye, Yao-Han, Zhou, Wen-Jun, Xu, Hui-Hui, Gan, Jun, Yan, Wei-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717930/ https://www.ncbi.nlm.nih.gov/pubmed/33329527 http://dx.doi.org/10.3389/fimmu.2020.565759 |
Ejemplares similares
-
Prognostic Significance of Immune Checkpoints HLA-G/ILT-2/4 and PD-L1 in Colorectal Cancer
por: Chen, Qiong-Yuan, et al.
Publicado: (2021) -
Heterogeneity of HLA-G Expression in Cancers: Facing the Challenges
por: Lin, Aifen, et al.
Publicado: (2018) -
The Role of HLA-G in Human Papillomavirus Infections and Cervical Carcinogenesis
por: Xu, Hui-Hui, et al.
Publicado: (2020) -
Predictive value of different proportion of lesion HLA-G expression in colorectal cancer
por: Zhang, Rui-Li, et al.
Publicado: (2017) -
HLA-G/ILTs Targeted Solid Cancer Immunotherapy: Opportunities and Challenges
por: Lin, Aifen, et al.
Publicado: (2021)